Demographic Factors Associated with Presenting for Eye Evaluation in the Partnership for Research on Vaccines and Infectious Diseases in Liberia III Natural History Study of Ebola Virus Disease

PURPOSE: Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD. METHODS: The Pa...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Middle East African journal of ophthalmology Ročník 30; číslo 2; s. 103 - 106
Hlavní autori: Wallace, Augustine C. D., Ross, Robin D., Tawse, Kirstin, Nyain, Ruth, Gargu, Catherine, Wentworth, Deborah E., Bishop, Rachel J., Eghrari, Allen O.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: India Wolters Kluwer - Medknow 01.04.2023
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Vydanie:2
Predmet:
ISSN:0974-9233, 0975-1599, 0975-1599, 0974-9233
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract PURPOSE: Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD. METHODS: The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Ebola natural history study is a 5-year study that seeks to identify long-term sequelae of EVD, including ocular sequelae. All survivors enrolled in the PREVAIL parent study from June 2015 to March 2016 were asked to return for comprehensive eye examination through June 2016. Logistic regression was conducted using self-reported survivor status, age, gender, and distance from the hospital as covariates. RESULTS: A total of 1448 subjects enrolled in the parent PREVAIL III longitudinal cohort during the defined window, of which 1375 (95.0%) followed up for baseline eye examination. Ebola survivors (635/661, 96.1%) and adult close contacts (727/767, 94.8%) demonstrated a comparable likelihood for presenting for eye examination (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.36-1.28). In an adjusted model, age over 50 (OR 10.2, 95% CI 1.35-77.3) and living outside Montserrado County (OR 0.18, 95% CI 0.10-0.33) were associated with the likelihood of presenting for a baseline comprehensive eye examination. CONCLUSION: Most EVD survivors and their close contacts who enrolled during the study window presented for eye examinations. Older participants and those who lived closer to clinical facilities were most likely to present. Focused strategies accounting for these factors may assist with organizations planning survivor care in the setting of EVD.
AbstractList Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD. The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Ebola natural history study is a 5-year study that seeks to identify long-term sequelae of EVD, including ocular sequelae. All survivors enrolled in the PREVAIL parent study from June 2015 to March 2016 were asked to return for comprehensive eye examination through June 2016. Logistic regression was conducted using self-reported survivor status, age, gender, and distance from the hospital as covariates. A total of 1448 subjects enrolled in the parent PREVAIL III longitudinal cohort during the defined window, of which 1375 (95.0) followed up for baseline eye examination. Ebola survivors (635/661, 96.1) and adult close contacts (727/767, 94.8) demonstrated a comparable likelihood for presenting for eye examination (odds ratio [OR] 0.68, 95 confidence interval [CI] 0.36-1.28). In an adjusted model, age over 50 (OR 10.2, 95 CI 1.35-77.3) and living outside Montserrado County (OR 0.18, 95 CI 0.10-0.33) were associated with the likelihood of presenting for a baseline comprehensive eye examination. Most EVD survivors and their close contacts who enrolled during the study window presented for eye examinations. Older participants and those who lived closer to clinical facilities were most likely to present. Focused strategies accounting for these factors may assist with organizations planning survivor care in the setting of EVD.
PURPOSE: Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD. METHODS: The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Ebola natural history study is a 5-year study that seeks to identify long-term sequelae of EVD, including ocular sequelae. All survivors enrolled in the PREVAIL parent study from June 2015 to March 2016 were asked to return for comprehensive eye examination through June 2016. Logistic regression was conducted using self-reported survivor status, age, gender, and distance from the hospital as covariates. RESULTS: A total of 1448 subjects enrolled in the parent PREVAIL III longitudinal cohort during the defined window, of which 1375 (95.0) followed up for baseline eye examination. Ebola survivors (635/661, 96.1) and adult close contacts (727/767, 94.8) demonstrated a comparable likelihood for presenting for eye examination (odds ratio [OR] 0.68, 95 confidence interval [CI] 0.36-1.28). In an adjusted model, age over 50 (OR 10.2, 95 CI 1.35-77.3) and living outside Montserrado County (OR 0.18, 95 CI 0.10-0.33) were associated with the likelihood of presenting for a baseline comprehensive eye examination. CONCLUSION: Most EVD survivors and their close contacts who enrolled during the study window presented for eye examinations. Older participants and those who lived closer to clinical facilities were most likely to present. Focused strategies accounting for these factors may assist with organizations planning survivor care in the setting of EVD. Keywords: Ebola, Liberia, post-ebola syndrome, Partnership for Research on Vaccines and Infectious Diseases in Liberia
PURPOSE:Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD.METHODS:The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Ebola natural history study is a 5-year study that seeks to identify long-term sequelae of EVD, including ocular sequelae. All survivors enrolled in the PREVAIL parent study from June 2015 to March 2016 were asked to return for comprehensive eye examination through June 2016. Logistic regression was conducted using self-reported survivor status, age, gender, and distance from the hospital as covariates.RESULTS:A total of 1448 subjects enrolled in the parent PREVAIL III longitudinal cohort during the defined window, of which 1375 (95.0%) followed up for baseline eye examination. Ebola survivors (635/661, 96.1%) and adult close contacts (727/767, 94.8%) demonstrated a comparable likelihood for presenting for eye examination (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.36-1.28). In an adjusted model, age over 50 (OR 10.2, 95% CI 1.35-77.3) and living outside Montserrado County (OR 0.18, 95% CI 0.10-0.33) were associated with the likelihood of presenting for a baseline comprehensive eye examination.CONCLUSION:Most EVD survivors and their close contacts who enrolled during the study window presented for eye examinations. Older participants and those who lived closer to clinical facilities were most likely to present. Focused strategies accounting for these factors may assist with organizations planning survivor care in the setting of EVD.
PURPOSE: Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD. METHODS: The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Ebola natural history study is a 5-year study that seeks to identify long-term sequelae of EVD, including ocular sequelae. All survivors enrolled in the PREVAIL parent study from June 2015 to March 2016 were asked to return for comprehensive eye examination through June 2016. Logistic regression was conducted using self-reported survivor status, age, gender, and distance from the hospital as covariates. RESULTS: A total of 1448 subjects enrolled in the parent PREVAIL III longitudinal cohort during the defined window, of which 1375 (95.0%) followed up for baseline eye examination. Ebola survivors (635/661, 96.1%) and adult close contacts (727/767, 94.8%) demonstrated a comparable likelihood for presenting for eye examination (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.36-1.28). In an adjusted model, age over 50 (OR 10.2, 95% CI 1.35-77.3) and living outside Montserrado County (OR 0.18, 95% CI 0.10-0.33) were associated with the likelihood of presenting for a baseline comprehensive eye examination. CONCLUSION: Most EVD survivors and their close contacts who enrolled during the study window presented for eye examinations. Older participants and those who lived closer to clinical facilities were most likely to present. Focused strategies accounting for these factors may assist with organizations planning survivor care in the setting of EVD.
Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD. The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Ebola natural history study is a 5-year study that seeks to identify long-term sequelae of EVD, including ocular sequelae. All survivors enrolled in the PREVAIL parent study from June 2015 to March 2016 were asked to return for comprehensive eye examination through June 2016. Logistic regression was conducted using self-reported survivor status, age, gender, and distance from the hospital as covariates. A total of 1448 subjects enrolled in the parent PREVAIL III longitudinal cohort during the defined window, of which 1375 (95.0%) followed up for baseline eye examination. Ebola survivors (635/661, 96.1%) and adult close contacts (727/767, 94.8%) demonstrated a comparable likelihood for presenting for eye examination (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.36-1.28). In an adjusted model, age over 50 (OR 10.2, 95% CI 1.35-77.3) and living outside Montserrado County (OR 0.18, 95% CI 0.10-0.33) were associated with the likelihood of presenting for a baseline comprehensive eye examination. Most EVD survivors and their close contacts who enrolled during the study window presented for eye examinations. Older participants and those who lived closer to clinical facilities were most likely to present. Focused strategies accounting for these factors may assist with organizations planning survivor care in the setting of EVD.
Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD.PURPOSESurvivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the likelihood to present for eye examination among Ebola survivors enrolled in a longitudinal natural history study of EVD.The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Ebola natural history study is a 5-year study that seeks to identify long-term sequelae of EVD, including ocular sequelae. All survivors enrolled in the PREVAIL parent study from June 2015 to March 2016 were asked to return for comprehensive eye examination through June 2016. Logistic regression was conducted using self-reported survivor status, age, gender, and distance from the hospital as covariates.METHODSThe Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) III Ebola natural history study is a 5-year study that seeks to identify long-term sequelae of EVD, including ocular sequelae. All survivors enrolled in the PREVAIL parent study from June 2015 to March 2016 were asked to return for comprehensive eye examination through June 2016. Logistic regression was conducted using self-reported survivor status, age, gender, and distance from the hospital as covariates.A total of 1448 subjects enrolled in the parent PREVAIL III longitudinal cohort during the defined window, of which 1375 (95.0%) followed up for baseline eye examination. Ebola survivors (635/661, 96.1%) and adult close contacts (727/767, 94.8%) demonstrated a comparable likelihood for presenting for eye examination (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.36-1.28). In an adjusted model, age over 50 (OR 10.2, 95% CI 1.35-77.3) and living outside Montserrado County (OR 0.18, 95% CI 0.10-0.33) were associated with the likelihood of presenting for a baseline comprehensive eye examination.RESULTSA total of 1448 subjects enrolled in the parent PREVAIL III longitudinal cohort during the defined window, of which 1375 (95.0%) followed up for baseline eye examination. Ebola survivors (635/661, 96.1%) and adult close contacts (727/767, 94.8%) demonstrated a comparable likelihood for presenting for eye examination (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.36-1.28). In an adjusted model, age over 50 (OR 10.2, 95% CI 1.35-77.3) and living outside Montserrado County (OR 0.18, 95% CI 0.10-0.33) were associated with the likelihood of presenting for a baseline comprehensive eye examination.Most EVD survivors and their close contacts who enrolled during the study window presented for eye examinations. Older participants and those who lived closer to clinical facilities were most likely to present. Focused strategies accounting for these factors may assist with organizations planning survivor care in the setting of EVD.CONCLUSIONMost EVD survivors and their close contacts who enrolled during the study window presented for eye examinations. Older participants and those who lived closer to clinical facilities were most likely to present. Focused strategies accounting for these factors may assist with organizations planning survivor care in the setting of EVD.
Audience Academic
Author Tawse, Kirstin
Wallace, Augustine C. D.
Eghrari, Allen O.
Bishop, Rachel J.
Ross, Robin D.
Gargu, Catherine
Wentworth, Deborah E.
Nyain, Ruth
AuthorAffiliation 1 Partnership for Research on Vaccines and Infectious Diseases in Liberia Eye Clinic, JFK Hospital, Monrovia, Liberia
3 Colorado Permanente Medical Group, Denver, Colorado, USA
4 Department of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA
5 Wilmer Eye Institute, Johns Hopkins, Baltimore, Maryland, USA
2 University of Arizona College of Medicine, Phoenix, Arizona, USA
AuthorAffiliation_xml – name: 1 Partnership for Research on Vaccines and Infectious Diseases in Liberia Eye Clinic, JFK Hospital, Monrovia, Liberia
– name: 5 Wilmer Eye Institute, Johns Hopkins, Baltimore, Maryland, USA
– name: 3 Colorado Permanente Medical Group, Denver, Colorado, USA
– name: 2 University of Arizona College of Medicine, Phoenix, Arizona, USA
– name: 4 Department of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA
Author_xml – sequence: 1
  givenname: Augustine C. D.
  surname: Wallace
  fullname: Wallace, Augustine C. D.
– sequence: 2
  givenname: Robin D.
  surname: Ross
  fullname: Ross, Robin D.
– sequence: 3
  givenname: Kirstin
  surname: Tawse
  fullname: Tawse, Kirstin
– sequence: 4
  givenname: Ruth
  surname: Nyain
  fullname: Nyain, Ruth
– sequence: 5
  givenname: Catherine
  surname: Gargu
  fullname: Gargu, Catherine
– sequence: 6
  givenname: Deborah E.
  surname: Wentworth
  fullname: Wentworth, Deborah E.
– sequence: 7
  givenname: Rachel J.
  surname: Bishop
  fullname: Bishop, Rachel J.
– sequence: 8
  givenname: Allen O.
  surname: Eghrari
  fullname: Eghrari, Allen O.
  email: allen@jhmi.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39006926$$D View this record in MEDLINE/PubMed
BookMark eNp9k11vmzAUhtHUae26_oDdTJYmTbtJZmPAcDVFabpGirZqH721jDkEp2CntmmUn7d_NifpR1JtAwnQ4XmPj19eXkdH2miIorcEDxOC6acOxMIMt1eeUh6TF9EJLlg6IGlRHG2fk0ERU3ocnTm3wJuDYZbmr6JjWmCcFXF2Ev0-h87MrVg2SqILIb2xDo2cM1IJDxVaKd-gKwsOtFd6jmpj0WQNaHIn2l54ZTRSGvkG0JWwXoN1jVpuqe9BI6xsUECuhZRKg0NCV2iqa5BB2Tt0rgLjQj30mKkSrBJoOp2ir8L3VrToUrkw0Br98H21RqZGk9K0Al0r-yR-E72sRevg7P5-Gv26mPwcXw5m375Mx6PZQKZ5thwIFracsxJXJK-IzNKcyQzHNBZpJkqK6yopK8gwi0lRkErUMTAGCcU4lzQBRk-jz7u-y77soJLBkDAiX1rVCbvmRih--Earhs_NHSckpnkwO3T4eN_BmtsenOedchLaVmgIbnCKc5zRlKUkoO-foQvTWx32xylJUhZnWZw-UXPRAle6NmFhuWnKR3mMCUtisll2-BcqnBV0SoZQ1SrUDwQf9gQNiNY3zrT95mu7Q_DdviWPXjzEKwBkB0hrnLNQPyIE802K-S6_eykOGvZMI5XfJi2Mrdr_Ksc75cq0PiTxpu1XYANS3Wiz-reQb6oP_wH9A-EtE5I
CitedBy_id crossref_primary_10_1097_IIO_0000000000000535
Cites_doi 10.1167/tvst.10.1.32
10.1111/j.1365-3156.2004.01205.x
10.1056/NEJMoa1805435
10.1001/jama.2014.17934
10.1371/journal.pone.0104128
10.9745/GHSP-D-16-00226
10.3389/fpubh.2016.00142
10.3109/08820538.2016.1154171
10.1016/j.survophthal.2012.07.005
10.1056/NEJMc1506576
10.1001/jamanetworkopen.2020.32216
ContentType Journal Article
Copyright Copyright: © 2024 Middle East African Journal of Ophthalmology
Copyright: © 2024 Middle East African Journal of Ophthalmology.
COPYRIGHT 2023 Medknow Publications and Media Pvt. Ltd.
2023. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright: © 2024 Middle East African Journal of Ophthalmology 2024
Copyright_xml – notice: Copyright: © 2024 Middle East African Journal of Ophthalmology
– notice: Copyright: © 2024 Middle East African Journal of Ophthalmology.
– notice: COPYRIGHT 2023 Medknow Publications and Media Pvt. Ltd.
– notice: 2023. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright: © 2024 Middle East African Journal of Ophthalmology 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
5PM
DOI 10.4103/meajo.meajo_53_21
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList

ProQuest Health & Medical Complete (Alumni)


MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 0975-1599
0974-9233
Edition 2
EndPage 106
ExternalDocumentID PMC11238926
A820174216
39006926
10_4103_meajo_meajo_53_21
MEJO-30-103
Genre Multicenter Study
Journal Article
GeographicLocations Liberia
United States
GeographicLocations_xml – name: Liberia
– name: United States
GroupedDBID ---
29M
2WC
5VS
7X7
88E
8FI
8FJ
8G5
ABDBF
ABJNI
ABUWG
ABXLX
ACGFS
ACUHS
ADBBV
ADRAZ
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BENPR
BPHCQ
BVXVI
CCPQU
DIK
DWQXO
E3Z
EBD
EJD
EOJEC
ESX
F5P
FYUFA
GNUQQ
GUQSH
GX1
H13
HMCUK
HYE
IAO
IEA
IHR
IHW
IL9
INH
INR
ITC
KQ8
M1P
M2O
M48
O5R
O5S
OBODZ
OK1
OVD
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PMFND
PQQKQ
PROAC
PSQYO
RMW
RNS
RPM
TEORI
TR2
TUS
UKHRP
W3E
AAYXX
ADJBI
AFFHD
CITATION
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
5PM
ID FETCH-LOGICAL-c586p-a700687b0d18d1c6587c60232a56ab30fd4bde60721991daf2e77e43008c34e73
IEDL.DBID W3E
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001253562300004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0974-9233
0975-1599
IngestDate Thu Aug 21 18:32:18 EDT 2025
Fri Sep 05 13:35:19 EDT 2025
Tue Oct 07 05:56:58 EDT 2025
Mon Oct 20 22:46:39 EDT 2025
Mon Oct 20 16:55:00 EDT 2025
Thu May 22 21:24:09 EDT 2025
Mon Jul 21 06:05:50 EDT 2025
Sat Nov 29 05:57:21 EST 2025
Tue Nov 18 21:29:59 EST 2025
Wed May 28 23:11:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Liberia
post-ebola syndrome
Ebola
Partnership for Research on Vaccines and Infectious Diseases in Liberia
Language English
License Copyright: © 2024 Middle East African Journal of Ophthalmology.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c586p-a700687b0d18d1c6587c60232a56ab30fd4bde60721991daf2e77e43008c34e73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doi.org/10.4103/meajo.meajo_53_21
PMID 39006926
PQID 3145726625
PQPubID 226464
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11238926
proquest_miscellaneous_3080635751
proquest_journals_3145726625
gale_infotracmisc_A820174216
gale_infotracacademiconefile_A820174216
gale_healthsolutions_A820174216
pubmed_primary_39006926
crossref_primary_10_4103_meajo_meajo_53_21
crossref_citationtrail_10_4103_meajo_meajo_53_21
wolterskluwer_medknow_10_4103_meajo_meajo_53_21_103_Demograp
PublicationCentury 2000
PublicationDate 2023-04-01
PublicationDateYYYYMMDD 2023-04-01
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-01
  day: 01
PublicationDecade 2020
PublicationPlace India
PublicationPlace_xml – name: India
– name: Riyadh
PublicationTitle Middle East African journal of ophthalmology
PublicationTitleAlternate Middle East Afr J Ophthalmol
PublicationYear 2023
Publisher Wolters Kluwer - Medknow
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Publisher_xml – name: Wolters Kluwer - Medknow
– name: Medknow Publications and Media Pvt. Ltd
– name: Medknow Publications & Media Pvt. Ltd
References Gillespie (R1-20240830) 2016; 4
Sneller (R6-20240830) 2019; 380
Senyonjo (R8-20240830) 2014; 9
Elam (R11-20240830) 2013; 58
Umfress (R7-20240830) 2016; 31
Melese (R9-20240830) 2004; 9
(R10-20240830) 2001; 14
Epstein (R3-20240830) 2015; 373
Eghrari (R13-20240830) 2021; 10
Eghrari (R12-20240830) 2021; 4
Shultz (R4-20240830) 2015; 313
Rabelo (R5-20240830) 2016; 4
References_xml – volume: 14
  start-page: 1
  year: 2001
  ident: R10-20240830
  publication-title: Community Eye Health
– volume: 10
  start-page: 32
  year: 2021
  ident: R13-20240830
  article-title: Efficacy and safety outcomes of cataract surgery in survivors of Ebola virus disease:12-month results from the PREVAIL VII study
  publication-title: Transl Vis Sci Technol
  doi: 10.1167/tvst.10.1.32
– volume: 9
  start-page: 426
  year: 2004
  ident: R9-20240830
  article-title: Indirect costs associated with accessing eye care services as a barrier to service use in Ethiopia
  publication-title: Trop Med Int Health
  doi: 10.1111/j.1365-3156.2004.01205.x
– volume: 380
  start-page: 924
  year: 2019
  ident: R6-20240830
  article-title: Alongitudinal study of Ebola sequelae in Liberia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1805435
– volume: 313
  start-page: 567
  year: 2015
  ident: R4-20240830
  article-title: The 2014 Ebola outbreak and mental health:Current status and recommended response
  publication-title: JAMA
  doi: 10.1001/jama.2014.17934
– volume: 9
  start-page: e104128
  year: 2014
  ident: R8-20240830
  article-title: Ocular morbidity and health seeking behaviour in Kwara state, Nigeria:Implications for delivery of eye care services
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0104128
– volume: 4
  start-page: 626
  year: 2016
  ident: R1-20240830
  article-title: Social mobilization and community engagement central to the Ebola response in West Africa:Lessons for future public health emergencies
  publication-title: Glob Health Sci Pract
  doi: 10.9745/GHSP-D-16-00226
– volume: 4
  start-page: 142
  year: 2016
  ident: R5-20240830
  article-title: Psychological distress among Ebola survivors discharged from an Ebola treatment unit in Monrovia, Liberia –A qualitative study
  publication-title: Front Public Health
  doi: 10.3389/fpubh.2016.00142
– volume: 31
  start-page: 432
  year: 2016
  ident: R7-20240830
  article-title: Eye Care Disparities and Health-Related Consequences in Elderly Patients with Age-Related Eye Disease
  publication-title: Semin Ophthalmol
  doi: 10.3109/08820538.2016.1154171
– volume: 58
  start-page: 348
  year: 2013
  ident: R11-20240830
  article-title: High-risk populations for vision loss and eye care underutilization:A review of the literature and ideas on moving forward
  publication-title: Surv Ophthalmol
  doi: 10.1016/j.survophthal.2012.07.005
– volume: 373
  start-page: 2484
  year: 2015
  ident: R3-20240830
  article-title: Post-ebola signs and symptoms in U. S. survivors
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc1506576
– volume: 4
  start-page: e2032216
  year: 2021
  ident: R12-20240830
  article-title: Characterization of Ebola virus-associated eye disease
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2020.32216
SSID ssj0000070758
Score 2.2552364
Snippet PURPOSE: Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with...
Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with the...
PURPOSE: Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with...
PURPOSE:Survivors of Ebola virus disease (EVD) are at risk for ocular complications after infection. We sought to identify demographic factors associated with...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 103
SubjectTerms Adolescent
Adult
Aged
Child
Child, Preschool
Communicable diseases
Disease susceptibility
Ebola virus
Ebola virus infections
Ebolavirus - immunology
Eye
Eye Diseases - epidemiology
Eye examinations
Eye Infections, Viral - epidemiology
Eye Infections, Viral - virology
Female
Health aspects
Hemorrhagic Fever, Ebola - epidemiology
Hemorrhagic Fever, Ebola - prevention & control
Humans
Infectious diseases
Liberia - epidemiology
Male
Medical examination
Medical research
Medicine, Experimental
Middle Aged
Natural history
Original
Original Article
Risk Factors
Survivors
Vaccines
Young Adult
Title Demographic Factors Associated with Presenting for Eye Evaluation in the Partnership for Research on Vaccines and Infectious Diseases in Liberia III Natural History Study of Ebola Virus Disease
URI https://doi.org/10.4103/meajo.meajo_53_21
https://www.ncbi.nlm.nih.gov/pubmed/39006926
https://www.proquest.com/docview/3145726625
https://www.proquest.com/docview/3080635751
https://pubmed.ncbi.nlm.nih.gov/PMC11238926
Volume 30
WOSCitedRecordID wos001253562300004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEMX
  databaseName: Medknow Open Access Journals
  customDbUrl:
  eissn: 0975-1599
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000070758
  issn: 0974-9233
  databaseCode: W3E
  dateStart: 20070101
  isFulltext: true
  titleUrlDefault: http://www.medknow.com/journals.asp
  providerName: Wolters Kluwer Health
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEA96igji98fqeY4gCEK1TdomC74c3i4u6LIPut5bSNMsVr3usb1T9s_zP3Mm6fa2hwriSx-aSfox08lvmplfGHtWKCIJKVxUKFVGqXEuwmmBR9YqI9BrZonnLZi_k9OpOjwczlqyaKqF2Vq_T5NYvDpy5svypT_qTGgqGb_EZcIpzvokzn6neNoavxtnjAg5Qtgiwhrm70fpzULnffHWZHQ-UfLajyUtYjdffQ771kw0vvEPz3CTXW_hJuwH-7jFLrj6Nrvyvl1Qv8N-HrijQFpdWRiHvXdgozJXAv2mhVkoUcJJDhDiwmjtYNSRhENVA4JImKEN1iEp2kttUvoARebG0uUaMHUJkzb967SBg7A61NAYPnWlMjCZTGBqPBsIBA6TNVCy4xqWCxgVGInDvFqddb7LPo5HH968jdpdHSKbqfw4MpLKUmQRl4kqE4sISNockQM3WW4KES_KtChdTrxtiF1Ls-BOSpcKBCtWpE6Ke2ynXtbuAQNl09gVnBtnZZrzohC2zFQphhhiKzS7AYs3Wta2pTynnTe-aQx9SDU6KGVLNQP2outyHPg-_ib8hExHh5LVzlfofYJVMuVJPmDPvQR5C7yyNW3RA94_8W71JHd7kviV237zxjx162UaLZI0k4iweDZgT7tm6kmZc7VDTWqBIQFxDmZ4t_eDNXcPJoZEVM1xcNWz806AuMf7LXX12XOQI0xHqEtdX_c-CXw9vorzzy9N09mNcT_8v-6P2FWOphMyqXbZzsnq1D1ml-33k6pZ7bGL8lDteT_xC_FkbDQ
linkProvider Wolters Kluwer Health
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Demographic+Factors+Associated+with+Presenting+for+Eye+Evaluation+in+the+Partnership+for+Research+on+Vaccines+and+Infectious+Diseases+in+Liberia+III+Natural+History+Study+of+Ebola+Virus+Disease&rft.jtitle=Middle+East+African+journal+of+ophthalmology&rft.au=Nyain%2C+Ruth&rft.au=Gargu%2C+Catherine&rft.au=Tawse%2C+Kirstin&rft.au=Wallace%2C+Augustine+C.+D&rft.date=2023-04-01&rft.pub=Medknow+Publications+and+Media+Pvt.+Ltd&rft.issn=0974-9233&rft.volume=30&rft.issue=2&rft.spage=103&rft_id=info:doi/10.4103%2Fmeajo.meajo_53_21&rft.externalDBID=n%2Fa&rft.externalDocID=A820174216
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0974-9233&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0974-9233&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0974-9233&client=summon